Robinson Lab
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
||||
|
||||
|
|
|
|
|
|
|
Our lab studies the molecular mechanisms of and develops therapies to treat autoimmune and rheumatic diseases, with a focus on rheumatoid arthritis, osteoarthritis, multiple sclerosis, and systemic lupus erythematosus.
The overriding objectives of our laboratory are:
-
To investigate the mechanisms underlying autoimmune and rheumatic diseases.
-
To develop novel diagnostics and therapeutics for autoimmune and rheumatic diseases.
-
To investigate the role of inflammation in osteoarthritis.
We perform translational research, with the goal of rapidly converting discoveries made at the bench into practical patient care tools and therapies.
We are part of the Division of Immunology and Rheumatology in the Department of Medicine, the Program in Immunology, and the Institute for Immunity Transplantation and Infection (ITI), at Stanford University School of Medicine. We are also part of the GRECC at the Palo Alto VA Health Care System.
